Literature DB >> 12615525

The earlier age of onset of malignancy in developing world is related to overall infection burden and could be due to the effect on telomere length.

P S R K Sastry1, Purvish Parikh.   

Abstract

It is a common observation that many common cancers occur at a younger age in developing countries, like India. The cancer registry data provide incidence rate of different cancers, which suggest the same. Telomere shortening is involved in ageing of cells. Inflammation and infection result in telomere shortening in immune cells. The higher infection burden in developing countries might mean an earlier ageing of immune cells, resulting in decreased efficiency of immune surveillance and thus predisposing to cancer at an earlier age than seen in developed countries with lesser infection burden. Copyright 2003 Elsevier Science Ltd.

Entities:  

Mesh:

Year:  2003        PMID: 12615525     DOI: 10.1016/s0306-9877(03)00030-6

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  4 in total

Review 1.  Telomere shortening and Alzheimer's disease.

Authors:  Zhiyou Cai; Liang-Jun Yan; Anna Ratka
Journal:  Neuromolecular Med       Date:  2012-11-16       Impact factor: 3.843

2.  TERT's role in colorectal carcinogenesis.

Authors:  Andrew J Pellatt; Roger K Wolff; Jennifer Herrick; Abbie Lundgreen; Martha L Slattery
Journal:  Mol Carcinog       Date:  2012-02-21       Impact factor: 4.784

3.  Telomere length in peripheral leukocyte DNA and gastric cancer risk.

Authors:  Lifang Hou; Sharon A Savage; Martin J Blaser; Guillermo Perez-Perez; Mirjam Hoxha; Laura Dioni; Valeria Pegoraro; Linda M Dong; Witold Zatonski; Jolanta Lissowska; Wong-Ho Chow; Andrea Baccarelli
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-10-27       Impact factor: 4.254

4.  Transforming growth factor β signaling pathway associated gene polymorphisms may explain lower breast cancer risk in western Indian women.

Authors:  Narendra N Joshi; Mithila D Kale; Sujata S Hake; Sadhana Kannan
Journal:  PLoS One       Date:  2011-08-04       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.